As a result, roflumilast, a selective inhibitor of phosphodiesterase-4 (PDE-4) that promotes BDNF expression and alleviates depression-induced neuronal injury and apoptosis, induces CREB phosphorylation, similar to Zhang et al. [46]. The gene discussed is PDE4A; the disease is depressive disorder.